Cell line · CVCL_1697
SJSA-1
Cancer cell line, Homo sapiens. Osteosarcoma. 45 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SJSA-1. Cell lines, record CVCL_1697. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1697
On this page
Cell line
As Cellosaurus gives it.
- Name
- SJSA-1
- Accession
- CVCL_1697
- RRID
- RRID:CVCL_1697
- Synonyms
- SJSA1, SJSA, OsA-CL, OSA-CL, OsACL, OSACL, Os-A, OSA, OsA
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 19Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone, femur (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers45
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A triple-action PROTAC for wild-type p53 cancer therapy. | Cell Rep Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression. | J Transl Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Biological Activity of Biomarkers Associated With Metastasis in Osteosarcoma Cell Lines. | Cancer Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma. | Cell Rep Med | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 45
See all 45 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | S_M6R1 | CVCL_HG09 | Cell lines | |
| Derived from it | S_N40R2 | CVCL_HG10 | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-2098 | ATCC | |
| AddexBio | C0004004/64 | Cellosaurus | |
| CCTCC | GDC0257 | Cellosaurus | |
| CLS | 305096 | CLS | |
| Hysigen | TCH-C327 | Hysigen |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1697
GET https://conductscience.org/api/cell-lines/v1/CVCL_1697/papers?page=2